Crossmark

Breiterer Einsatz von Tislelizumab

Crossref DOI link: https://doi.org/10.1007/s15004-024-0672-4

Published Online: 2024-07-25

Published Print: 2024-07

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Maugg, Doris
License Information

Text and Data Mining valid from 2024-07-01

Version of Record valid from 2024-07-01
More Information

Article History

First Online: 25 July 2024

Free to read: This content has been made available to all.